Janney Montgomery Scott
ENTA icon

Janney Montgomery Scott’s Enanta Pharmaceuticals ENTA Stock Holding History

Janney Montgomery Scott’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-62,452
Closed -$698K – 2667
2023
Q3 		$698K Buy
+62,452
New +$1.01M ﹤0.01% 1553
2018
Q3 		– Sell
-3,065
Closed -$355K – 2080
2018
Q2 		$355K Hold
3,065
– – ﹤0.01% 1567
2018
Q1 		$248K Buy
+3,065
New +$236K ﹤0.01% 1701

Other funds holding ENTA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janney Montgomery Scott's ENTA Position: Q4 2023 in Review

Janney Montgomery Scott sold out of Enanta Pharmaceuticals (ENTA) in Q4 2023, closing a stake of 62,452 shares — an estimated $698K sold.

Janney Montgomery Scott first reported a position in ENTA in Q1 2018 and held it in 3 quarters. The position peaked at $698K in Q3 2023. 105 funds tracked by Wall St. Rank hold ENTA as of Q4 2023.

  • Janney Montgomery Scott reported no remaining Enanta Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 62,452 Enanta Pharmaceuticals shares in Q4 2023, an estimated $698K.
  • Janney Montgomery Scott first reported a position in Enanta Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Janney Montgomery Scott's Enanta Pharmaceuticals position peaked at $698K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2023.

Based on Janney Montgomery Scott's 13F filing for Q4 2023, filed 8 Feb 2024.